|
Neoplasia
Citations 51-60 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies
- Beata U. Orzechowska, Michael F. Powers, Jerald Sprague, He Li, Bonnie Yen, Robert P. Searles, Michael K. Axthelm, and Scott W. Wong
Blood 2008; 112: 4227-4234.
[Abstract]
[Full text]
[PDF]
An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma
- Wei Xiong, Xiaosong Wu, Sarah Starnes, Sarah K. Johnson, Jeff Haessler, Siqing Wang, Lijuan Chen, Bart Barlogie, John D. Shaughnessy, Jr, and Fenghuang Zhan
Blood 2008; 112: 4235-4246.
[Abstract]
[Full text]
[PDF]
A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma
- Qing Lan, Unhee Lim, Chin-San Liu, Stephanie J. Weinstein, Stephen Chanock, Matthew R. Bonner, Jarmo Virtamo, Demetrius Albanes, and Nathaniel Rothman
Blood 2008; 112: 4247-4249.
[Abstract]
[Full text]
[PDF]
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
- Sigurdur Y. Kristinsson, Thomas R. Fears, Gloria Gridley, Ingemar Turesson, Ulf-Henrik Mellqvist, Magnus Björkholm, and Ola Landgren
Blood 2008; 112: 3582-3586.
[Abstract]
[Full text]
[PDF]
Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
- Wing-Yan Au, Sidney Tam, Bonnie M. Fong, and Yok-Lam Kwong
Blood 2008; 112: 3587-3590.
[Abstract]
[Full text]
[PDF]
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
- Laura Rosiñol, José Antonio Pérez-Simón, Anna Sureda, Javier de la Rubia, Felipe de Arriba, Juan José Lahuerta, José David González, Joaquín Díaz-Mediavilla, Belén Hernández, Javier García-Frade, Dolores Carrera, Angel León, Miguel Hernández, Pascual Fernández Abellán, Juan Miguel Bergua, Jesús San Miguel, and Joan Bladé, for Programa para el Estudio y la Terapéutica de las Hemopatías Malignas y Grupo Español de Mieloma (PETHEMA/GEM)
Blood 2008; 112: 3591-3593.
[Abstract]
[Full text]
[PDF]
PEBP2-β/CBF-β–dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis
- Hee-Jun Wee, Dominic Chih-Cheng Voon, Suk-Chul Bae, and Yoshiaki Ito
Blood 2008; 112: 3777-3787.
[Abstract]
[Full text]
[PDF]
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
- Joshua Arnold, Bevin Zimmerman, Min Li, Michael D. Lairmore, and Patrick L. Green
Blood 2008; 112: 3788-3797.
[Abstract]
[Full text]
[PDF]
IRF-4 functions as a tumor suppressor in early B-cell development
- Jaime Acquaviva, Xiaoren Chen, and Ruibao Ren
Blood 2008; 112: 3798-3806.
[Abstract]
[Full text]
[PDF]
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
- Chris Pepper, Thet Thet Lin, Guy Pratt, Saman Hewamana, Paul Brennan, Louise Hiller, Robert Hills, Rachel Ward, Jane Starczynski, Belinda Austen, Laura Hooper, Tatjana Stankovic, and Chris Fegan
Blood 2008; 112: 3807-3817.
[Abstract]
[Full text]
[PDF]
|
|
